8987 related articles for article (PubMed ID: 1706743)
1. Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope.
Cuomo M; Nicotra MR; Apollonj C; Fraioli R; Giacomini P; Natali PG
J Invest Dermatol; 1991 Apr; 96(4):446-51. PubMed ID: 1706743
[TBL] [Abstract][Full Text] [Related]
2. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
Tomita Y; Hearing VJ
Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.
McEwan M; Parsons PG; Moss DJ; Burrows S; Stenzel D; Bishop CJ; Strutton GM
Pigment Cell Res; 1989; 2(1):1-7. PubMed ID: 2470076
[TBL] [Abstract][Full Text] [Related]
5. Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes.
Tomita Y; Montague PM; Hearing VJ
J Invest Dermatol; 1985 Nov; 85(5):426-30. PubMed ID: 2414367
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody MAT-1 against human tyrosinase can detect melanogenic cells on formalin-fixed paraffin-embedded sections.
Sato N; Suzuki S; Takimoto H; Masui S; Shibata K; Nakano H; Tomita Y
Pigment Cell Res; 1996 Apr; 9(2):72-6. PubMed ID: 8857669
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
McEwan M; Parsons PG; Moss DJ
J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
[TBL] [Abstract][Full Text] [Related]
8. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes.
Der JE; Dixon WT; Jimbow K; Horikoshi T
Br J Cancer; 1993 Jan; 67(1):47-57. PubMed ID: 7678981
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulins.
McElveen JE; Furtado PB; Smith SJ; Clark MR; Spendlove I; Sewell HF; Shakib F
Mol Pathol; 2000 Apr; 53(2):77-82. PubMed ID: 10889906
[TBL] [Abstract][Full Text] [Related]
10. Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies.
Jaanson N; Möll K; Kulla A; Ustav M
Melanoma Res; 2003 Oct; 13(5):473-82. PubMed ID: 14512789
[TBL] [Abstract][Full Text] [Related]
11. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody.
Thomson TM; Mattes MJ; Roux L; Old LJ; Lloyd KO
J Invest Dermatol; 1985 Aug; 85(2):169-74. PubMed ID: 3926906
[TBL] [Abstract][Full Text] [Related]
12. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
[TBL] [Abstract][Full Text] [Related]
13. Human yolk-sac tumor antigen 2G10: biochemical characterization and significance as a serum antigen.
Tanaka S; Fujimoto J; Ishii E; Hata J
Int J Cancer; 1989 Nov; 44(5):788-94. PubMed ID: 2479605
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of antibodies against human tyrosinase.
Bouchard B; Vijayasaradhi S; Houghton AN
J Invest Dermatol; 1994 Mar; 102(3):291-5. PubMed ID: 7509835
[TBL] [Abstract][Full Text] [Related]
16. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of specific asialoglycoprotein receptor antibodies.
Kohgo Y; Kato J; Nakaya R; Mogi Y; Yago H; Sakai Y; Matsushita H; Niitsu Y
Hybridoma; 1993 Oct; 12(5):591-8. PubMed ID: 8300135
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
19. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
20. The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus.
Tomita Y; Shibahara S; Takeda A; Okinaga S; Matsunaga J; Tagami H
J Invest Dermatol; 1991 Apr; 96(4):500-4. PubMed ID: 1706745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
